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A B S T R A C T
Operative treatment of epileptogenic cavernous malformations (CM) continues under debate. Most
studies focus on surgery for supratentorial CM in general. For temporal lobe CM, surgical decision-
making concerns in particular whether to perform lesionectomy alone or the additional excision of
mesial temporal structures. The purpose of this case series was to evaluate operative strategies used to
treat epileptogenic temporal CM and to report resultant postoperative seizure outcomes.
Twelve consecutive cases of patients with medically intractable epilepsy who underwent operation
for temporal CM between 1996 and 2006were retrospectively reviewed.When the temporal CM directly
invaded the hippocampus or amygdala, the affected structures were resected in addition to the lesion;
when the CM was located in the superﬁcial temporal cortex, and there was no radiographic evidence of
hippocampal sclerosis, lesionectomy alone was done; with CM located between the superﬁcial temporal
cortex and the mesial temporal region, other factors were considered in decision-making, such as lesion
proximity to the deep mesiotemporal structures and preoperative epilepsy duration.
For six of the twelve patients, extended lesionectomy (EL) alone was done; for the other six, tailored
anteromedial temporal resection with hippocampectomy and/or amygdalectomy was performed in
addition to EL. Postoperatively, 11 patients – all with preoperative VEM demonstrating electroclinical
seizure patterns concordant with lesion location – were seizure-free. We conclude that epileptogenic
temporal CM are surgically remediable, when approached with the above operative strategies and
presurgical VEM. On the basis of these postoperative seizure control results, we recommend
consideration of concurrent resection of mesial temporal structures with EL for certain temporal CM.
 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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The management of cavernous malformations (CM) causing
seizures continues to be the subject of vigorous debate. Cerebral
CM are angiographically occult vascular lesions found in approxi-
mately 0.5% of the population according to autopsy and imaging
studies. They are often epileptogenic when supratentorial.1–4Abbreviations: AED, anti-epileptic drug; AMTR, anteromedial temporal resection;
CM, cavernous malformations; DVA, developmental venous anomaly; ECoG,
electrocorticography; EL, extended lesionectomy; VEM, video EEG monitoring.
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1059-1311/$ – see front matter  2009 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2009.11.006Cerebral CM consist of abnormal, enlarged blood-ﬁlled vascular
channels with hyalinized walls, without interposed brain paren-
chyma. They have a clinically signiﬁcant prospective hemorrhage
rate of approximately 3% per patient/year after diagnosis.5,6
Chronic often undetected microhemorrhages of these lesions
result in iron deposition in adjacent brain tissue in the form of
hemosiderin, and the iron in this perilesional hemosiderin is
thought to play a major role in their epileptogenicity.7–11 Seizures
are in fact the most common initial presentation of supratentorial
CM, and patients with seizures due to CM often go on to develop
epilepsy that is medically intractable.3,5,6,12–17
A consensus about treatment options for epileptogenic CM is
arising from recent investigations. Most studies focus on the
outcomes of surgery for supratentorial CM in general, and these
analyses have provided evidence that for appropriately selectedvier Ltd. All rights reserved.
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than medical treatment.17,18 In addition, multiple studies have
demonstrated beneﬁt of extended lesionectomy for epileptogenic
CMs, as compared to restricted lesionectomy, with respect to
postoperative seizure control.11,19–21 However, few studies ad-
dress the details of operative approach for CM according to their
speciﬁc anatomic location.22,23 Questions regarding optimal
surgical approach for epileptogenic CM located in the temporal
lobe are still unanswered.
Surgical decision-making for individual cases of epileptogenic
temporal CM is challenging. The aim of this study was to examine
the presurgical evaluation, operative strategies, and seizure
control outcomes in a consecutive series of surgically treated
patients with medically intractable epilepsy and temporal lobe
CM, to make explicit all factors considered in decision-making for
optimal operative management. For CM located in the temporal
lobe, operative planning concerns whether these lesions should be
treated with lesionectomy alone or with the additional excision of
mesiotemporal structures. For this reason we examined in
particular the factors weighed in decisions whether to resect the
hippocampus and/or amygdala concurrently with the temporal
CM.
We used a speciﬁc surgical strategy algorithm for decision-
making in the operative treatment of temporal CM. In general, in
temporal CM cases in which anteromedial temporal resection is
not originally performed with the lesionectomy, if the patient still
has seizures postoperatively, a second operation is often
performed to resect the deep mesiotemporal structures. We used
a speciﬁc surgical strategy algorithm to achieve good postopera-
tive seizure control, obviating the need for re-operation.
2. Methods
2.1. Subjects
Twelve consecutive patients (seven men and ﬁve women) with
medically intractable epilepsy who underwent operative treat-
ment for temporal CM between 1996 and 2006 were identiﬁed in
the epilepsy surgery databases of UCLA Medical Center. Inclusion
criteria consisted of: medically intractable epilepsy, temporal
lesion with radiographic appearance consistent with CM, video
scalp EEG monitoring (VEM) evaluation, pathologically conﬁrmed
diagnosis of the resected temporal lesion as CM, and minimum
postoperative follow-up of 12 months. Patients with more than
one supratentorial CM were included (cases 5 and 6). Medically
intractable epilepsy was deﬁned as failure of pharmacologic
seizure control with adequate trials of at least two ﬁrst-line anti-
epileptic drugs (AEDs).24–26
2.2. Data analyzed
Data retrospectively analyzed consisted of age at ﬁrst seizure
and at operation; seizure type and frequency; AED history;
neurologic disease other than epilepsy; pre- and postoperative
neurologic examination; preoperative MRI ﬁndings including
number, location, and size (maximum diameter) of CM, as well
as radiographic evidence of hippocampal sclerosis; VEM data;
FDG-PET; neurocognitive testing; Wada test results when done;
intraoperative ﬁndings; pathologic specimens; and postoperative
seizure control outcomes. Institutional Review Board approval for
the study was obtained (UCLA IRB G09-04-094-01).
2.3. Preoperative evaluation
The preoperative evaluation in the 12 cases included:MRI, scalp
VEM, FDG-PET, and neurocognitive testing. One patient underwentinterictal MEG (case 6). When deemed necessary, Wada test
was performed in the cases in which hippocampal resection was
considered in combination with lesionectomy. (Wada test was
done in four of the ﬁve hippocampal-resection cases: done in cases
4, 8, 9, 11, not done in case 12.) One patient underwent
preoperative fMRI to assess language (case 2).
2.3.1. Preoperative MRI
Preoperative MRI scans obtained in all patients via 1.5 T
scanner included axial T1-weighted images, axial and coronal T2-
weighted images, and axial gradient-echo T2-weighted images.
Through 2003, MRI included T1-weighted spoiled gradient-echo
(SPGR) sequences and after 2003, T1-weighted magnetization-
prepared rapid gradient-echo (MPRAGE) sequences. In patients
who did not undergo digital-subtraction cerebral angiogram
(DSA) as part of a Wada test, axial and coronal T1-weighted
sequences were acquired after gadolinium injection for enhanced
MR sequences to assess for developmental venous anomaly
(DVA).
2.3.2. Preoperative VEM
Preoperative VEM scalp recordings were obtained in all 12
patients, with a minimum of three clinically stereotypical seizures
separated by at least 8 h recorded. Preoperative or intraoperative
invasive recordings were recorded in three patients: extraopera-
tive recording from subdural grid and strip electrodes in one
patient (case 2) and intraoperative electrocorticography (ECoG) in
two patients (cases 1 and 2).
2.4. Surgical procedures
All operations were performed by one surgeon (I.F.) and
consisted of extended lesionectomy either alone or combined
with tailored anteromedial temporal resection (AMTR). Extend-
ed lesionectomy is deﬁned here as microsurgical resection of the
cavernous malformation and perilesional tissue with abnormal
appearance on direct intraoperative visualization.11 The tailored
AMTR operations differed in whether both or part of the
hippocampus and/or amygdala were microsurgically resected.
(See Section 3 and Table 1.) These tailored procedures always
involved resection of anterior temporal neocortex (anterior
middle temporal gyrus and inferior temporal gyrus) of 3–3.5 cm
in the dominant hemisphere and 3.5–4 cm in the non-dominant
hemisphere, as well as the anterior 1 cm of the superior
temporal gyrus (STG). (The term ‘tailored’ is deﬁned here as
‘ﬁtted’ to the diagnostic data, including ictal EEG ﬁndings from
scalp VEM, and is not meant to imply the use of invasive EEG
recording. Intraoperative ECoG was used only in select cases
when deemed useful by the epileptologist and surgeon.)
Developmental venous anomalies (DVAs) associated with CM
were not resected.
2.4.1. Algorithm of surgical strategy for epileptogenic temporal CM
1. Selection of patients for operation was based on electroclinical
congruence of scalp VEM ictal EEG with the location of CM on
MRI.
2. In patients with multiple supratentorial CM, ictal EEG ﬁndings
were used to identify a single epileptogenic CM to be resected.
3. If the temporal CM directly invaded the hippocampus or
amygdala, the involved structure was resected in addition to
the lesion.
4. If the temporal CM was located in the superﬁcial temporal
neocortex far from the hippocampus and amygdala, and there
was no radiographic evidence of hippocampal sclerosis,
extended lesionectomy alone was done.
Table 1
Clinical, operative, and outcome data of 12 consecutive patients with epileptogenic temporal CM.
Pt Ages +duration MRI: temp CM loc (size) EEG PET Ncog/Wada Operation Outcome
(months)
Onset/op (yrs) (Size: diameter in cm) Interictal (ed) Ictal
+Other ﬁndings on MRI
1 14/49+35 R Posterior inf temp (1.1) F8, S2 F8, S2 No hyp NA/+ R EL IA (120)
2 14/44+30 L Fusiform gyrus (2.0) None L cent temp Ips hyp +/+ L EL+MST IB (108)
3 17/37+20 L Fusiform gyrus (1.5) T1, T3+T2, T4 None Ips hyp +/+ L EL IV (64)
4 26/53+26 R Hipp head (1.7) F8, S2 F8, S2 Ips hyp +/+ R Hippocampectomy+EL ID (12)
+Other ﬁnding: R HS (rad)
5 20/25+5 R MTG (1.0) T2, T4 T2 Ips hyp +/ND R EL IB (70)
+Other lesion: R parietal CM (1.2)
6 33/42+9 L Fusiform gyrus (0.8) T1 T1, T3 Ips hyp +/ND L EL IC (55)
+Other lesions: L Ant parietal CM (1.5), L Posterior frontal CM (1.0), R Frontal CM (1.0)
7 12/21+9 L TP, encr. amygdala (2.3) T1, T3 T1, T3 Ips hyp +/ND L Partial amygdalectomy+EL IA (45)
8 40/46+6 L Hipp body (1.4) T3 T1 Ips hyp +/+ L Hippocampectomy+EL IA (24)
+Other lesion: DVA beneath L Hipp CM
9 6/54+48 R TP (1.1) None T2 Ips hyp +/+ R Amygd-hippocamp+EL IB (25)
+Other lesion: R frontal DVA
10 26/30+4 R MTG (1.1) None T2 Ips hyp +/ND R EL IA (24)
11 39/43+4 R PHG (1.4) T2+T1 T2 Ips hyp +/+ R Amygd-hippocamp+EL ID (26)
12 33/47+14 Mesial to R Hipp head (1.3) T2+T1 R FT Ips hyp +/ND R Amygd-hippocamp+EL IA (25)
The clinical data includes age at seizure onset, age at operation, epilepsy duration prior to operation. The diagnostic data includes MRI ﬁndings (location and diameter of
lesions), EEG ﬁndings (interictal and ictal), FDG-PET ﬁndings (interictal hypometabolism), and whether neurocognitive test and Wada test were done. The operative and
outcome data includes type of operation, postoperative seizure outcomes (Engel classes), and longest duration follow-up (months) in 12 patients with epileptogenic temporal
CM.
Amygd-hippocamp: microsurgical resection of amygdala and hippocampus; ant: anterior; cent: central CM: cavernous malformation; duration: epilepsy duration prior to
operation (years); DVA: developmental venous anomaly; ed: epileptiform discharges; EL: extended lesionectomy; encr.: encroaching upon; Hipp: hippocampal; HS (rad):
hippocampal sclerosis (radiographic evidence for); inf: inferior; Ips hyp: ipsilateral temporal hypometabolism (ipsilateral to the lesion location onMRI); L: left;MST:multiple
subpial transaction; MTG:mesial temporal gyrus; NA: done but results not available; Ncog: neurocognitive test; ND: not done; no hyp: no hypometabolism; onset/op: age at
seizure onset/age at operation (years); PET: interictal FDG-PET study; PHG: parahippocampal gyrus; R: right; temp: temporal; TP: temporal pole; and +: study done and
results available.
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and the deep mesiotemporal structures, other factors were
considered in the decision whether or not to resect the
hippocampus and amygdala, such as proximity of the CM to
the mesial temporal region, preoperative duration of epilepsy,
and effects of prior treatment modalities.
6. All surgical decisions were constrained by functional data,
including neurocognitive, Wada, and fMRI ﬁndings, and
tempered by direct operative visualization.
7. DVAs associated with CM were not resected.
2.5. Outcome evaluation
Postoperative seizure control outcomes were assessed at clinic
visits or with follow-up clinical telephone calls, using Engel’s
classiﬁcation as follows: ‘‘class IA, completely seizure-free since
surgery; class IB, nondisabling simple partial seizures only since
surgery; class IC, some disabling seizures after surgery, but free of
disabling seizures for at least two years; class ID, generalized
convulsion with AED withdrawal only; class II, rare disabling
seizures; class III, worthwhile improvement; class IV, no worth-
while improvement’’.27 The standard postoperative AED protocol
consisted of continuation of patients’ preoperative AED regimen
for a minimum of two years postoperatively.
3. Results
3.1. Demographic and presurgical evaluation results
The mean age of subjects at seizure onset was 23 (range: 6–40
years old). The mean age at operation was 41 (range: 21–54 years
old). The mean preoperative epilepsy duration was 17.5 years
(range: 4–48 years). Table 1 shows these data for all patients andall pertinent diagnostic data, including MRI ﬁndings (location and
diameter of lesions), EEG ﬁndings (interictal and ictal), FDG-PET
ﬁndings (interictal hypometabolism), and whether neurocognitive
and Wada tests were done.
3.2. Operative and postoperative results
Table 1 shows for all patients: type of operation, postoperative
seizure outcomes based on the Engel classiﬁcation, and longest
duration follow-up.
3.2.1. Morbidity and mortality
There were no operative or perioperative morbidities or
mortality.
3.2.2. Types of operation
For six of the twelve patients, extended lesionectomy alonewas
done, with sparing of the mesial temporal structures (cases 1, 2, 3,
5, 6, 10). Of these six lesionectomy cases, three were right-sided
and three were left-sided. For the other six patients, tailored
variations of AMTR with resection of the hippocampus and/or
amygdala were performed, in combination with extended
lesionectomy (cases 4, 7, 8, 9, 11, 12). Of these six cases, four
were right-sided and two were left-sided. In ﬁve of these six cases,
the hippocampus was resected (four right-sided and one left-
sided). In one of these six cases, partial resection of the amygdala
was done in addition to extended lesionectomy,with sparing of the
hippocampus (case 7). The CMwas completely resected in 11 of the
12 cases. Partial extended lesionectomy of the CMwas necessary in
one case due to a DVA encasing the patient’s left hippocampal CM
(case 8). In this case the DVA was not resected, as per standard of
care, to avoid the risk of interrupting venous drainage of normal
brain tissue.
Fig. 1.MRI brain scan of case 9, preoperative, showing right temporal pole CM. (A)
MR brain coronal T2 image. (B) MR brain axial T2 image.
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In the six patientswho underwent extended lesionectomy alone,
the epileptogenic CMdid not have amesial temporal location. Itwas
located in the temporal neocortex in ﬁve (cases 2, 3, 5, 6, 10) and in
the central temporal lobe white matter between the neocortical
temporal andmesial temporal regions inonecase (case1). For thesix
patients who underwent tailored AMTR variants in addition to
extended lesionectomy, the CM directly involved the amygdala or
hippocampus in three cases (cases 4, 7, 8), was located between the
lateral temporal neocortex and the mesial temporal region in one
case (case 9), and was in a mesial temporal location in very close
proximity to the amygdala and hippocampus in two cases (case 11,
in the right PHG; case 12, mesial to the right hippocampal head).
3.2.4. Wada test and type of operation
For the two patients with left temporal CMwho had poor verbal
memory scores after the left-sided injection in the Wada test,
extended lesionectomy alone was done (cases 2 and 3). For one of
the six cases in which hippocampal resection was planned, Wada
test was not done for logistical reasons (case 12): The patient had
high seizure frequency (three to four seizures per day) and a non-
dominant hemisphere lesion, with CM located mesial to the right
hippocampal head. Given the distance at which the patient lived
from tertiarymedical care, pursuit ofWada testwould have further
delayed an already-delayed operation. The patient underwent
right AMTR with microsurgical resection of the hippocampus and
amygdala combined with extended lesionectomy.
3.2.5. Postoperative follow-up and seizure outcomes
The mean postoperative follow-up period for the 12 patients
was 50 months (range: 12–120months). Eleven patients – all with
preoperative VEM demonstrating electroclinical seizure patterns
congruent with the location of the subsequently resected lesion –
were seizure-free (Engel class I). One patient (case 3) had no
postoperative improvement in epilepsy status (Engel class IV)
(follow-up 64 months). This patient had interictal EEG ﬁndings
suggestive of bilateral independent temporal epileptogenic zones
and ictal VEM recordings that were non-localizing and non-
lateralizing; her operation was performed with palliative intent.
Twopatientshadmore thanonesupratentorial CM.Bothpatients
wereseizure-freeafter resectionofoneCMonly, i.e. after resectionof
the temporal CM that had been identiﬁed by VEM as epileptogenic
(cases 5 and 6). In case 5, scalp VEM indicated that the patient’s right
temporal CM–rather than the right parietal CM–wasepileptogenic.
The patient’s continued postoperative seizure freedom after
extended lesionectomy of the right temporal CM alone conﬁrmed
the VEM results regarding epileptogenicity (follow-up 70 months).
In case 6, scalp VEM showed the patient’s left temporal CM to be
epileptogenic, rather than the right frontal or two left parietal CM.
Similarly, the patient’s continued postoperative seizure freedom
after extended lesionectomy of the left temporal CM alone was
conﬁrmatory of the VEM ﬁndings (follow-up 55 months).
3.3. Pathologic results
For all 12 patients, the resected temporal lesion was identiﬁed
as a CM by gross and histopathologic examination. In the ﬁve cases
in which the hippocampus was resected, the hippocampal
specimens were analyzed pathologically. Two hippocampi (cases
4 and 9) showed granule cell dispersion in the dentate gyrus, a
ﬁnding generally restricted to TLE patients and found in 40% of
hippocampal sclerosis cases.28–30 One of these two patients had
radiographic evidence of hippocampal sclerosis predictive of these
hippocampal pathologic ﬁndings (case 4). One hippocampal
specimen – from a patient whose temporal CM involved the body
of the hippocampus – showed deformation grossly and vascularcalcinosis histologically (case 8). Two hippocampal specimens
consisted of material insufﬁcient for histopathologic analysis
(cases 11 and 12).
4. Results: illustrative case
Case 9 is described to provide an example of factors involved in
the decision to resect the mesiotemporal structures concomitant
with extended lesionectomy.
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4.1.1. Extended lesionectomy combined with AMTR, microsurgical
resection of hippocampus and amygdala
This 54-year-old right-handed man presented with pharmaco-
logically refractory complex partial seizures, onset at age six years.
As a business owner, he found that his chronic seizure disorder
limited the expansion of his company and prevented independent
travel. Neurologic examination showed no gross or focal deﬁcits.
MRI revealed a 1.1 cm lesion radiographically consistent with CM
in the right temporal pole, anterior to the parahippocampal gyrus.
(See Fig. 1.) MRI also showed the right hippocampus to be slightly
smaller than the left, but there was no focal signal abnormality
suggestive of hippocampal sclerosis. Epilepsy evaluation included
[i] scalp VEM revealing electrographic seizure onset in the right
mesial temporal region, [ii] interictal FDG-PET showing moderate
right temporal hypometabolism, and [iii] neuropsychologic test
ﬁndings consistent with subtle right and left mesial temporal
dysfunction, suggestive of ‘crowding’ of functions into the left
mesial temporal region. Wada test with right-sided injection
showed left hemispheric dominance for language and a good
memory score (87%). Given (a) all data congruent for right
temporal epileptogenic zone in the region of the CM, (b) the
proximity of the epileptogenic lesion to the amygdala/hippocam-
pal head, as well as (c) the patient’s lengthy epilepsy duration (48
years), decision was made to offer the patient right AMTR
(including microsurgical resection of the hippocampus and
amygdala) with extended lesionectomy, as most likely to improveFig. 2. Surgical specimen of CM lesion in case 9. (A) This low power view of whole mou
closely together. (B) This high power view shows thrombosed vascular channels in the
channels without interposed neural tissue. (D) This lower power view shows the hemthe patient’s seizure control. Operative ﬁndings included: the right
temporal pole CM itself, surrounded by abnormal tissue with
yellow discoloration, affecting the head of the hippocampus and
partially the amygdala. The abnormal hemosiderin staining
extended to the entorhinal cortex, the anterior border of the
hippocampus, and the amygdala, as well as the parahippocampal
region. Histopathology conﬁrmed the lesion as a CM (see Fig. 2);
the hippocampal specimen showed granule cell dispersion. The
patient’s postoperative seizure outcome was Engel class IB (no
seizures and one de´ja` vu aura) at 25 months follow-up, on his
continued two AED regimen. Functionally, he has continued to
work successfully as the owner of his own business and is now
driving and traveling independently.
4.1.2. Decision to resect mesiotemporal structures based on multiple
factors in case 9
This case illustrates the fact that: when CM do not directly
involve the hippocampus and amygdala, decision-making about
whether to resect these mesial temporal structures concurrently
with extended lesionectomy is based on multiple factors, such as
lesion location and preoperative epilepsy duration here.
5. Discussion
We report 12 cases of surgically treated epileptogenic temporal
CM with details of their presurgical evaluation, operative
treatment, and postoperative seizure control outcomes, to address
still open questions about optimal operative strategy for thesent of lesion shows three fragments of the CM containing hyalinized vessels packed
CM. (C) This high power view of the CM shows back-to-back hyalinized vascular
osiderin-stained tissue surrounding the CM.
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combining a literature review with their own case series of
epileptogenic supratentorial CM.15 Their series included 11
patients with temporal CM treated with lesionectomy, with
postoperative seizure outcomes classiﬁed as Engel class I in six,
class II in one, class III in one, and class IV in three cases. Only one of
those 11 patients underwent AMTR/amygdalohippocampectomy,
done subsequent to the initial lesionectomy due to lack of
postoperative improvement in seizure control. That is, this patient
required a second operation consisting of AMTR/amygdalohippo-
campectomy, which then resulted in worthwhile improvement in
seizure control (Engel class III). Another CM case series included 12
temporal CM treated initially with lesionectomy and – similar to
Moran’s series – described one patient with no improvement in
postoperative seizure control who later underwent AMTR/amyg-
dalohippocampectomy with subsequent seizure freedom (in that
series, case #13).31 In discussing the postoperative seizure control
outcomes both in the literature and in their own series, Moran and
colleagues stated: ‘‘It was only possible to analyze the outcome of
lesionectomy, as there are very few reported cases in which other
forms of surgery, particularly temporal lobectomy, were
employed. The increasing recognition of dual pathology . . .
however, makes this an area in need of further investigation’’.15
The existing literature has primarily focused on postoperative
seizure control outcomes, usually of lesionectomy, with omission
of the details of surgical approach. The majority of studies
reporting temporal CM grouped them with CM in other
supratentorial locations and considered a heterogeneous popula-
tion of patients — that is, patients with medically intractable
epilepsy and patients who have only had a few seizureswhich then
self-resolved or were well-controlled with AED monother-
apy.17,32,33 In their excellent large multicenter study, Baumann
et al. focused on postoperative outcomes and did not address
surgical decision-making regarding which temporal CM might
appropriately be treated by lesionectomy alone and which by
additional resection of themesial temporal structures.17 Given that
the focus of their study was not operative decision-making, they
generalized about surgical approach in their temporal CM cases,
stating that amygdalohippocampectomy was performed in most
patients with mesiotemporal CM.17
One other study has focused on the presurgical evaluation and
operative treatment of temporal lobeCM.23 InPaolini et al.’s series of
eightpatientswithdrug-resistantTLEandsolitary temporalCM, two
patients underwent lesionectomy alone and six underwent varia-
tions of temporal lobectomy in addition to lesionectomy. They
reportedexcellent postoperative seizureoutcomes for all eight cases
(Engel class I), with relatively short follow-up in two cases (follow-
up range: 2–46 months). They did not focus on explaining how the
decision was made to resect the mesiotemporal structures in their
four cases of temporal neocortical CM.Our case series addresses this
still unanswered question about the details of surgical decision-
making for epileptogenic temporal cavernous malformations.
Eleven of the twelve cases reported in our series had excellent
postoperative seizure control outcomes (Engel class I) after one
operation only. The pertinent question concerns what strategy led
to improved postoperative seizure control in these 11 cases, and
what led to failure of seizure reduction in one case in this series. To
answer this question, the surgical decision-making in these 12
cases is discussed here.
5.1. Surgical decision-making
For planning the optimal operative strategy for epileptogenic
temporal CM, scalp VEM and structural MRI were the two most
important factors. First, scalp VEM recording of ictal EEG was
necessary to establish electroclinical congruence with the ana-tomic location of the temporal CM seen on MRI, to localize a focal
epileptogenic zone. Second, the CM location on MRI was a heavily
weighted factor in decision-making about whether to resect the
mesiotemporal structures in addition to the lesion.When ictal EEG
and CM location on structuralMRIwere concordant, and other data
(FDG-PET, neurocognitive testing) were not contradictory, it was
the speciﬁc anatomic location of the CM within the temporal lobe
on structural MRI that carried the most weight in the decision to
perform extended lesionectomy alone versus extended lesionect-
omy combined with AMTR.
5.2. Scalp VEM ictal EEG
The importance of scalp VEM in the preoperative evaluation of
these epileptic patients’ supratentorial CM is consistent with other
studies’ results.31 In our case series, concordance of scalp VEM ictal
EEG ﬁndings with structural MRI was crucial to the selection of
patients for operative treatment, for good postoperative seizure
control. For 11 cases in our series – all the lesionectomy cases and
all cases of lesionectomy combinedwith AMTR inwhich scalp VEM
ictal EEG ﬁndings were congruent with the radiographic lesion –
the patientswere seizure-free postoperatively (Engel class I). In the
one lesionectomy case in which the ictal EEG was not focally
congruent with the radiographic lesion location, postoperative
seizure control was not improved (case 3, Engel class IV).
5.3. Role of ictal EEG in cases of multiple supratentorial CM
In the two epileptic patients with more than one supratentorial
CM in this series, use of scalp VEM data identiﬁed a single
epileptogenic CM (cases 5 and 6). (In one case, interictal
magnetoencephalography used as an adjunctive study conﬁrmed
the ictal EEG ﬁndings (case 6).) This identiﬁcation permitted
lesionectomy of one CM only in these two cases, with resultant
postoperative seizure freedom for both patients. Given that the
minimal resection possible is always a surgical goal, this use of
VEMbeneﬁts patientswithmultiple supratentorial CMundergoing
operative treatment for seizure control.
5.4. Anatomic relationship of temporal CM to the mesiotemporal
structures
Actual anatomic encroachment onmesiotemporal structures by
the CM was the most important factor in the decision to resect
them with the lesion. After involvement of the deep mesiotem-
poral structures by the CM shown on MRI was conﬁrmed by direct
operative inspection, these structures were then either completely
or partially resected, with constraint from functional data (cases 4,
7, 8). This functional constraint was provided by neurocognitive,
Wada, or fMRI ﬁndings and tempered by direct operative
visualization.
In all cases in this series in which the epileptogenic CM and the
surrounding hemosiderin-stained brain tissue were conﬁned to the
temporal neocortex, the mesial temporal structures were not
resected;extended lesionectomyalonewasdone (cases2,3,5,6,10).
In cases where the CM did not actually invade the mesiotemporal
structures and also was not located in the superﬁcial temporal
neocortex, but rather lay between the two regions, the decision
regardingwhether or not to take the hippocampus or amygdalawas
notobvious (cases1, 9, 11, 12). In suchcases the relativeproximityof
the CM to the mesiotemporal structures shown by MRI, clinical
history suchasprior treatmentmodalities andpreoperativeepilepsy
duration, as well as direct operative visualization of hemosiderin
staining all were important factors in the surgical decision-making.
In the one case in this series inwhich the epileptogenic temporal CM
was located in the central white matter of the temporal lobe
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were not resected; lesionectomy alone was done (case 1). In the
three cases in this series in which the CMwas in close proximity to
the mesiotemporal structures but not actually invading them, both
the hippocampus and amygdala were resected, in addition to the
lesion (cases 9, 11, 12). In case 9, the CM was located in the right
temporal pole near the parahippocampal gyrus. In addition to this
limbic proximity, the patient’s long duration of epilepsy (48 years)
also played a role in the decision to resect the deep mesiotemporal
structures in addition to extended lesionectomy. In case 11, the
patient had undergone stereotactic radiosurgery directed at the
right parahippocampal CMby other practitioners four years prior to
surgical evaluation; concern about possible radiation injury to the
mesial temporal region inﬂuenced the decision to resect the
hippocampus and amygdala along with the CM.
5.5. Role of functional data
The operative strategy in case 7 provides an example of
surgical decision-making based on anatomic involvement of the
mesiotemporal structures by the temporal CM with constraint
by functional data. In this case MRI showed the patient’s 2.3 cm
CM to be located in the left temporal pole, extending to involve
the left entorhinal cortex, parahippocampal gyrus, fusiform
gyrus, and encroaching upon the amygdala. Direct visualization
intraoperatively revealed that the CM actually invaded the left
amygdala but did not touch the hippocampus. In addition, the
hippocampus showed no abnormal yellowish stain, indicating
absence of hemosiderin deposition. Given neurocognitive
ﬁndings of excellent verbal memory, upon which the patient’s
profession depended, as well as direct operative visualization
revealing no gross hippocampal abnormality, the hippocampus
was spared, while the amygdala was partially resected in the
region of CM involvement, concurrently with extended lesio-
nectomy.
For temporal CM that did not directly invade the deep
mesiotemporal structures, functional data such as predicted verbal
memory deﬁcits on Wada testing also played a role in surgical
decision-making. For the two patients with CM located in the left
fusiform gyrus, Wada test results showing very poor verbal
memory scores after left-sided injection were one of the factors
weighed in the decision for extended lesionectomy alone (cases 2
and 3).
5.6. DVA associated with CM
Anatomic association of a developmental venous anomaly
with CM factored into the surgical decision-making in one case in
this series. DVAs, also called venous malformations, have not
been shown to be epileptogenic and should not be resected. They
consist of anomalous veins arrayed centripetally around a dilated
venous trunk, surrounded by normal brain parenchyma for
which they supply anomalous venous drainage.34,35 Resection of
a DVA can suddenly obstruct the venous drainage of normal brain
tissue, causing venous hypertension that may result in hemor-
rhage and/or infarction.34 While a DVA in a different location in
the brain is not considered in CM operative planning (e.g. the
right frontal DVA in case 10), direct encroachment of a DVA on a
CM can prevent complete resection of the lesion. In the one case
in this series in which a DVA encased the CM, partial
lesionectomy of the CM was necessary to avoid resection of
the DVA (case 8).
Reports in the literature regarding the percentage of CMs
associated with DVAs vary widely, from 2.1% to 59.6%.36 This wide
range in percentages is due to the different methods of data
acquisition used in the various studies, with study design rangingfrom retrospective analysis of imaging studies,36–38 prospective
MR and DSA,14 to direct operative inspection.39 DVAs can be
missed on MRI and then visualized directly during operation.39
Alternatively, they can be suspected on MRI due to gadolinium
enhancement and then found not to be present on direct operative
visualization, as in case 9 in this series.
5.7. Epilepsy duration as a factor in surgical decision-making
Preoperative epilepsy duration played a role in the decision to
resect the mesiotemporal structures in one patient (case 9).
Though the literature does not show complete agreement on this
issue, multiple case series have found an association of longer
preoperative epilepsy duration with poorer postoperative out-
come.20,21,33 Given these published reports, it has been accepted
opinion that for patients with lengthy preoperative epilepsy
duration and high seizure frequency, a more extensive resection
than simple lesionectomy – that is, resection including the
mesiotemporal structures – would more likely result in improved
postoperative seizure control. Recently, however, a large multi-
center study found the converse, i.e. no signiﬁcant association
between preoperative epilepsy duration and postoperative
seizure control.17 This study concerned supratentorial CM in
general, not speciﬁcally temporal CM, and did not detail the type
of operation performed for each temporal CM. The lack of
agreement in the literature on this point is not a reason to
disregard epilepsy duration as a factor in surgical decision-
making, since the question of impact of epilepsy duration on
postoperative seizure control outcome remains open. Long
epilepsy duration may result in hippocampal sclerosis.40 If this
does occur, then long preoperative epilepsy duration may be a
pertinent factor in the decision to resect the hippocampus
concomitant with lesionectomy. This remains an area of
speculation.
In our study, there appeared to be no relationship between
preoperative epilepsy duration and postoperative seizure out-
come. However, it is not clear what role that factor would have
played if mesiotemporal structures had not been resected. The
limited number of cases analyzed here constrains our ability to
make any conclusion about the association of preoperative
epilepsy duration with postoperative seizure control outcome.
5.8. Size of CM
Baumann et al.’s multicenter study found lesion diameter less
than 1.5 cm to be a signiﬁcant predictor for improved postopera-
tive seizure control, though only in the ﬁrst two years after
operation.17 In our series, the size of the CM did not appear to have
any association with postoperative seizure outcome, but again the
limited number of cases does not permit deﬁnitive statement.
5.9. Dual pathology
Of the ﬁve cases that included hippocampal resection, three
hippocampal specimens were analyzed; the three cases all had
hippocampal histopathologic ﬁndings consistent with a desig-
nation of dual pathology (cases 4, 8, 9), that is, these cases had
hippocampal abnormalities in addition to the temporal CM. This
dual pathology can be viewed as ‘hindsight’ conﬁrmation that the
decision to resect the mesiotemporal structures was a correct
one, just as these patients’ excellent postoperative seizure
control can likewise be viewed as evidence that a correct
decision was made. However, it is obviously impossible to know
what the postoperative seizure control outcome of a patient
would have been if the mesiotemporal structures had not been
resected.
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The patients in our case series are a homogenous population
with respect to two factors: all had medically intractable epilepsy
and all had a temporal lobe CM demonstrated by scalp VEM to be
epileptogenic. The homogeneity of the cases in our series gives
weight to our conclusions in discussing the operative treatment of
temporal lobe CM in patients with medically intractable epilepsy.
However, our strict inclusion criteria did not allow the collection of
large numbers of cases and for that reason did not permit
assessment of statistical signiﬁcance.
5.11. Evaluating our temporal CM surgical strategy algorithm
Our goal in following the surgical strategy algorithm for
temporal CM detailed in the Methods Section was excellent
postoperative seizure control, to obviate any need for re-operation.
There has in fact been no need for re-operation in these cases. The
only case in which Engel Class I postoperative seizure control was
not obtained was constrained by functional data, that is, the
mesiotemporal structures could not be resected given the Wada
test results. In this one case, only EL was performed, and this was
done with palliative rather than curative intent. (See Appendix B,
for details of case 3.).
6. Conclusions
Epileptogenic temporal CM are surgically remediable with
appropriate patient selection and careful operative planning.
When CM do not directly involve the hippocampus and amygdala,
decision-making about whether to resect these mesial temporal
structures concurrently with extended lesionectomy is based on
multiple factors. Carefully planned operative strategy following
the surgical algorithm described here typically leads to excellent
postoperative seizure control in patients with ictal VEM ﬁndings
concordant with CM location on structural MRI. The detailed data
that we report regarding surgical decision-making and outcomes
in 12 consecutive cases of epileptogenic temporal CM may be
useful in the selection of patients for operation, planning the
optimal surgical approach, and counseling patients with these
lesions.
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